Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin

Journal of Dermatology

Volumn 38, Issue 4, 2011, Pages 390-392

  Barysch, Marjam Jeanette ^a   Kamarashev, Jivko ^a   Lockwood, Lauren L ^a   Dummer, Reinhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; IMIQUIMOD;

ABSENCE OF SIDE EFFECTS; AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATOACANTHOMA; LETTER; LOW DRUG DOSE; SKIN EXAMINATION; SUN EXPOSURE; TREATMENT OUTCOME; TUMOR VOLUME;

ACITRETIN; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KERATOACANTHOMA; KERATOLYTIC AGENTS; SKIN NEOPLASMS;

EID: 79953076191     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00967.x     Document Type: Letter

References (10)

1. Consigli JE, Gonzalez ME, Morsino R, et al. Generalized eruptive keratoacanthoma (Grzybowski variant). Br J Dermatol 2000; 142: 800-803. (Pubitemid 30226400)
2. Oakley A, Ng S,. Grzybowski's generalized eruptive keratoacanthoma: remission with cyclophosphamide. Australas J Dermatol 2005; 46: 118-123. (Pubitemid 40704893)
3. Agarwal M, Chander R, Karmakar S, Walia R,. Multiple familial keratoacanthoma of Witten and Zak-A report of three siblings. Dermatology 1999; 198: 396-399. (Pubitemid 29335737)
4. Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R,. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol 2003; 139: 1325-1332. (Pubitemid 37248283)
5. Urosevic M, Dummer R, Conrad C, et al. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst 2005; 97: 1143-1153. (Pubitemid 41511214)
6. Di Lernia V, Ricci C, Albertini G,. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol 2004; 18: 626-629. (Pubitemid 39255764)
7. Urosevic M, Dummer R,. Role of imiquimod in skin cancer treatment. Am J Clin Dermatol 2004; 5: 453-458. (Pubitemid 40175263)
8. Pini AM, Koch S, Scharer L, French LE, Lauchli S, Hofbauer GF,. Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient. J Am Acad Dermatol 2008; 5 (Suppl): S116-S117.
9. Hsia E, Johnston MJ, Houlden RJ, Chern WH, Hofland HEJ,. Effects of topically applied acitretin in reconstructed human epidermis and the rhino mouse. J Invest Dermatol 2008; 128: 125-130. (Pubitemid 350249384)
10. Wong WY, Kolbusz RV, Goldberg LH, Guana A,. Treatment of a recurrent keratoacanthoma with oral isotretinoin. Int J Dermatol 1994; 33: 579-583. (Pubitemid 24255809)